Why the study?
Does dextran 70 prevent postoperative deep venous thrombosis in patients undergoing major surgery?
Does dextran 70 prevent postoperative deep venous thrombosis in patients undergoing major surgery?
Dextran 70 significantly reduces the incidence of deep venous thrombosis after major surgery.
Dextran 70 was associated with lower postoperative DVT rates; hypothesis-generating and should not yet change practice.
One hundred and six patients undergoing major surgery were given dextran 70-500 ml. during operation, 500 ml. on the following day, and then 500 ml. on alternate days until discharge. Of these patients, I developed a deep venous thrombosis after the operation (0-94 per cent). One hundred and one patients acted as control subjects and, of these, 10 developed deep venous thrombosis (9-9 per cent). This reduction in incidence of thrombosis is significant at the 2 per cent level, indicating that dextran 70, as macrodex 6 per cent in 5 per cent dextrose, in the régime given is a simple and effective means of reducing deep venous thrombosis after major surgery.
No takes yet. Share an insight, caveat, or question.
Carter et al. (1973) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: